Measles vaccination and inflammatory bowel disease: Controversy laid to rest?

Drug Safety

Volumn 24, Issue 13, 2001, Pages 939-946

  Davis, Robert L ^a,b,c   Bohlke, Kari ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b CENTER FOR HEALTH STUDIES   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES MUMPS VACCINE; MEASLES VACCINE;

COLON CROHN DISEASE; CORRELATION FUNCTION; DISEASE ASSOCIATION; DRUG SAFETY; HUMAN; INFECTION PREVENTION; MEASLES VACCINATION; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; ULCERATIVE COLITIS;

EID: 0035192202     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-200124130-00001     Document Type: Review

References (4)

1. Gollop JH, Phillips SF, Melton LJ, et al. Epidemiologic aspects of Crohn's disease: a population based study in Olmstead County, Minnesota, 1943-1982. Gut 1988; 29: 49-56
2. Barton, JR, Gillon S, Ferguson A. Incidence of inflammatory bowel disease in Scottish children between 1968 and 1983: marginal fall in ulcerative colitis, three-fold rise in Crohn's disease. Gut 1989; 20: 618-22
3. Calkins BM, Whittaker DJ, Rider AA, et al. Trends in incidence rates of ulcerative colitis and Crohn's disease. Dig Dis Sci 1984; 29: 10: 913-20
4. Shivananda S, Lennard-Jones J, Logan R, et al. Incidence of inflammatory bowel disease across Europe: is there any difference between north and south? Results of the European Study on Inflammatory Bowel Disease. Gut 1996; 39: 690-7